Rapid Micro Biosystems (RPID)
(Delayed Data from NSDQ)
$0.84 USD
-0.01 (-0.99%)
Updated May 22, 2024 03:59 PM ET
After-Market: $0.83 -0.01 (-1.07%) 7:58 PM ET
3-Hold of 5 3
B Value F Growth F Momentum D VGM
Fundamental Charts
About Cash from Investing (TTM)
The company's trailing twelve month (TTM) Cash from Investing is the sum of the company's past 12 months cash position resulting from any gains or losses from investments in the financial markets, operating activities, and changes resulting from amounts spent on investments in capital assets such as plant and equipment. When evaluating the Cash from Investing value, it is important to consider each of the various activities which contribute to the overall change in cash position. A company can have a negative cash flow from investing and have a positive cash from Cash from operations or financing.
RPID 0.84 -0.01(-0.99%)
Will RPID be a Portfolio Killer in May?
Zacks Investment Research is releasing its prediction for RPID based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for RPID
Rapid Micro Biosystems, Inc. (RPID) Reports Q1 Loss, Tops Revenue Estimates
Edwards Lifesciences (EW) Q1 Earnings and Revenues Top Estimates
RPID: What are Zacks experts saying now?
Zacks Private Portfolio Services
Rapid Micro Biosystems, Inc. (RPID) Reports Q3 Loss, Tops Revenue Estimates
Rapid Micro Biosystems, Inc. (RPID) Reports Q2 Loss, Tops Revenue Estimates
Alphatec (ATEC) Reports Q2 Loss, Tops Revenue Estimates
Other News for RPID
Analysts Offer Insights on Healthcare Companies: Rapid Micro Biosystems (RPID), COMPASS Pathways (CMPS) and Harrow Health (HROW)
Rapid Micro Biosystems Grapples with Soaring ESG Compliance Demands: A Financial Health Alert
Rapid Micro Biosystems Inc (RPID) Q1 2024 Earnings Call Transcript Highlights: Key Financial ...
RPID Stock Earnings: Rapid Micro Biosystems Misses EPS, Beats Revenue for Q1 2024
Rapid Micro Biosystems, Inc. (RPID) Q1 2024 Earnings Call Transcript